Pharma Technology Focus – Issue 64
In this issue: Using drugs after their expiration dates have passed, treating lactose intolerance, a closer look at CARB-X’s work on antibacterial R&D, helping nanomedicines reach their target, radioactive isotopes battling cancer, and more.
September's top stories: Positive opinion for Trelegy Ellipta, Teva agreed to sell assets in women’s health business
GSK and Innoviva received a positive opinion from CHMP for Trelegy Ellipta to treat COPD, and Teva agreed to sell assets in global women’s health business for $1.38bn. Pharmaceutical-technology.com wraps up key headlines from September.
How voice assistant technology could revolutionise clinical trials
A new research collaboration aims to improve both data collection and patient engagement in clinical trials by harnessing the power of voice recognition.
Hard nut to crack: new trial brings new hope for children with peanut allergies
Aimmune Therapeutics has just started a new European trial to treat peanut allergy in children. Elly Earls finds out what it will involve and why it’s been such a long time coming.
Pharma Technology Focus – Issue 63
In this issue: UK pharma industry takes NICE to court over price caps, Amazon’s potential to enter the US pharmacy industry, a new platform to capture molecules from fungi, the current state of drug development in osteoporosis, and more.